IMPACT OF THE 2017 GOLD STRATEGY ON TIOTROPIUM plus OLODATEROL RESPONSE

被引：0
|
作者：
Langton, D. [1 ,2 ]
Ferguson, G. [3 ]
Voss, F. [4 ]
Maltais, F. [5 ]
Groenke, L. [4 ]
Buhl, R. [6 ]
Watz, H. [7 ]
机构：
[1] Frankston Hosp, Thorac Med, Frankston, Vic, Australia
[2] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia
[3] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA
[4] Boehringer Ingelheim Corp, Ingelheim, Germany
[5] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada
[6] Johannes Gutenberg Univ Mainz, Mainz, Germany
[7] LungClin Grosshansdorf Pulm Res, Pulm Res Inst, Grosshansdorf, Germany
来源：
RESPIROLOGY | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TO 129
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [31] THE FIXED-DOSE COMBINATION OF TIOTROPIUM plus OLODATEROL HAS A RAPID ONSET OF ACTION IN PATIENTS WITH COPD
    Veale, A.
    Ferguson, G.
    Pizzichini, E.
    Flezar, M.
    Groenke, L.
    Korducki, L.
    RESPIROLOGY, 2016, 21 : 129 - 129
  • [32] Treatment With Tiotropium Plus Olodaterol Respimat Improves Physical Functioning Of COPD Patients In A Real Life Setting
    Haensel, M.
    Glaab, T.
    Sauer, R.
    Rubin, R.
    Buhl, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [33] LUNG FUNCTION WITH TIOTROPIUM PLUS OLODATEROL IN EAST ASIAN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Bai, Chunxue
    Buhl, Roland
    Lee, Sang Haak
    Lee, Kwan Ho
    Joens, Olaf
    Zhao, Yihua
    Ichinose, Masakazu
    RESPIROLOGY, 2015, 20 : 53 - 53
  • [34] The fixed-dose combination of tiotropium plus olodaterol has a rapid onset of action in patients with COPD
    Ferguson, Gary T.
    Pizzichini, Emilio
    Flezar, Matjaz
    Groenke, Lars
    Korducki, Lawrence
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [35] Systemic Manifestations of COPD and the Impact of Dual Bronchodilation with Tiotropium/Olodaterol on Cardiac Function and Autonomic Integrity
    Dimiene, Ieva
    Hoppenot, Deimante
    Vajauskas, Donatas
    Padervinskiene, Lina
    Rimkunas, Airidas
    Zemaitis, Marius
    Barkauskiene, Diana
    Lapinskas, Tomas
    Ereminiene, Egle
    Miliauskas, Skaidrius
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [36] Tiotropium plus olodaterol provides significant lung-function benefits compared to fluticasone plus salmeterol regardless of prior bronchodilator use
    Derom, Eric
    Beeh, Kai-Michael
    Echave-Sustaeta, Jose
    Gronke, Lars
    Zhai, Dongmei
    Bjermer, Leif
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [37] Cost-effectiveness of the fixed-dose combination tiotropium plus olodaterol based on the DYNAGITO trial results
    Hoogendoorn, Martine
    Ramos, Isaac Corro
    Baldwin, Michael
    Luciani, Laura
    Fabron, Cecile
    Detournay, Bruno
    Rutten-Van Molken, Maureen
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [38] Combined tiotropium plus olodaterol influences physical functioning in COPD: Results of an open-label observational study
    Ruediger, Sauer
    Haensel, Michaela
    Buhl, Roland
    Rubin, Roman A.
    Frey, Marcel
    Marseille, Andrea
    Glaab, Thomas
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [39] Pooled Safety Analysis Of Adjudicated Serious Adverse Events With The Fixed-Dose Combination Of Tiotropium plus Olodaterol
    Buhl, R.
    Tetzlaff, K.
    Korducki, L.
    Vogelmeier, C.
    McGarvey, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [40] Analysis Of The Efficacy And Safety Of The Fixed-Dose Combination Of Tiotropium plus Olodaterol In Patients With COPD By Initial Disease Severity
    Korn, S.
    Buhl, R.
    Gronke, L.
    Korducki, L.
    Amatto, V. C.
    Ferguson, G. T.
    Abrahams, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
12345